Single photon emission computed tomography (SPECT) findings of a patient with a novel prion mutation

Kosuke Matsuzono1, Ryuta Morihara, Kota Sato

  • 1Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Japan.

Insights

This study details a rare familial prion disease case. Single photon emission computed tomography (SPECT) detected brain blood flow changes missed by magnetic resonance imaging (MRI) over time.

Area of Science:

  • Neuroscience
  • Genetics
  • Radiology

Background:

  • Familial prion diseases are rare genetic disorders.
  • Prion gene mutations can lead to diverse neurological symptoms.
  • Early detection of prion diseases is crucial for management.

Observation:

  • A unique familial prion disease case presented with pan-autonomic failure, sensory neuropathy, and mild cognitive impairment.
  • Diffusion-weighted magnetic resonance imaging (MRI) and fluid attenuated inversion recovery MRI showed no abnormalities over 6-11 years.
  • Technetium-99m-labeled ethylcysteinate dimer single photon emission computed tomography (SPECT) revealed decreased cerebral blood flow in the parietal and occipital lobes, progressing over two years.

Findings:

  • SPECT identified abnormalities in cerebral blood flow that preceded or were not detected by MRI.
  • The slowly progressive nature of this prion mutation may influence imaging findings.
  • SPECT demonstrated evolving hypoperfusion correlating with mild cerebral atrophy on later MRI scans.

Implications:

  • SPECT imaging may be more sensitive than MRI in detecting early functional changes in certain slow-progressing prion diseases.
  • This case highlights the importance of considering functional imaging techniques like SPECT in diagnosing prion genetic mutations.
  • Understanding the differential sensitivity of imaging modalities is key for accurate prion disease diagnosis and monitoring.